Ranbaxy Laboratories

Ranbaxy Laboratories was an Indian pharmaceutical company known for developing, manufacturing, and distributing generic medicines worldwide. It played a significant role in making affordable medications accessible across many countries. The company produced a wide range of therapies, including antibiotics, cardiovascular drugs, and painkillers. In 2015, Ranbaxy was acquired by the Japanese pharmaceutical firm Daiichi Sankyo, and it now operates as part of their global organization. Despite its growth, Ranbaxy faced legal and regulatory challenges related to manufacturing practices, which affected its reputation temporarily. Overall, it was a major player in the global generic drug industry.